Dr. Rader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4881 NE Goodview Circle
Lee's Summit, MO 64064Phone+1 913-588-1227- Is this information wrong?
Summary
- Dr. Ryan Rader is a Clinical Assistant Professor of Medical Oncology at the University of Kansas with a primary focus on breast cancer. He completed his Hematology/Oncology fellowship at Duke University and internal medicine residency at Cleveland Clinic. He received his medical degree from University of Missouri-Columbia School of Medicine.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
Cleveland Clinic FoundationResidency, Internal Medicine, 2017 - 2020
University of Missouri-Columbia School of MedicineClass of 2017
Certifications & Licensure
KS State Medical License 2023 - 2025
MO State Medical License 2023 - 2025
NC State Medical License 2020 - 2024
OH State Medical License 2020 - 2023
AL State Medical License 2021 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsAnalysis of clinical and dermoscopic features for basal cell carcinoma neural network classificationBeibei Cheng, R. Joe Stanley, William V. Stoecker, Sherea M. Stricklin, Kristen A. Hinton
Skin Research and Technology. 2013-02-01 - 25 citationsEvidence for risk of cardiomyopathy with hydroxychloroquine.Sumpter, LS Tatro, WV Stoecker, RK Rader
Lupus. 2012-10-04 - 10 citationsThe Pink Rim Sign: Location of Pink as an Indicator of Melanoma in Dermoscopic ImagesRyan K. Rader, Katie S. Payne, Uday Guntupalli, Harold S. Rabinovitz, Maggie C. Oliviero
Journal of Skin Cancer. 2014-02-03
Press Mentions
Patient Selection Takes Priority as Standard of Cares Shift in HR+ and HER2+ Breast CanceJuly 14th, 2024
Professional Memberships
- Missouri State Medical AssociationStudent Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
